In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Detalles Bibliográficos
Autores principales: Anekpuritanang, Tauangtham, Klairmont, Matthew M., Gradowski, Joel, Hagiwara, Kohei, Bailey, Nathanael G., Chandra, Pranil, Liu, Yiwei, Mulder, Heather L., Easton, John, Zhang, Jinghui, Martin, Michael G., Owczarczyk, Anna B., Dunlap, Jennifer B., Fan, Guang, Press, Richard D., Raess, Philipp W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152993/
https://www.ncbi.nlm.nih.gov/pubmed/34559205
http://dx.doi.org/10.1182/bloodadvances.2021004983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152993/
https://www.ncbi.nlm.nih.gov/pubmed/34559205
http://dx.doi.org/10.1182/bloodadvances.2021004983

Ejemplares similares